Log in
Enquire now
‌

US Patent 11747297 Enhanced chloride selective membrane

Patent 11747297 was granted and assigned to Siemens Healthcare Diagnostics Inc. on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

TimelineTable: Further ResourcesReferences
Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Siemens Healthcare Diagnostics Inc.
Current Assignee
‌
Siemens Healthcare Diagnostics Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11747297
Patent Inventor Names
Bo Peng
David Thompson
Date of Patent
September 5, 2023
Patent Application Number
17652937
Date Filed
March 1, 2022
Patent Citations
‌
US Patent 7384523 Chloride ion selective membrane and sensor
Patent Citations Received
‌
US Patent 12085532 Enhanced chloride selective membrane
1
Patent Primary Examiner
‌
Gurpreet Kaur
CPC Code
‌
G01N 27/3335
‌
G01N 27/4166
‌
G01N 27/302
‌
G01N 27/301
‌
G01N 27/4167
‌
G01N 27/333

There is provided a chloride selective membrane including an epoxide-based matrix reacted with a stoichiometric amount of an amino compound and an activator such that the epoxide-based matrix comprises a number of quaternary ammonium groups.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11747297 Enhanced chloride selective membrane

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.